Disease Flares Among Early Rheumatoid Arthritis Patients Treated with Continued Methotrexate Either Alone or in Combination with Adalimumab (Humira)

被引:0
作者
Kavanaugh, Arthur [1 ]
van Vollenhoven, Ronald F. [2 ]
Sunkureddi, Prashanth [3 ]
Zhang, Ying [4 ]
Suboticki, Jessica L. [5 ]
Smolen, Josef S. [6 ,7 ]
机构
[1] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA
[2] Amsterdam Rheumatol & Immunol Ctr ARC, Amsterdam, Netherlands
[3] Univ Texas Med Branch, Galveston, TX 77555 USA
[4] AbbVie Inc, N Chicago, IL USA
[5] AbbVie Inc, Mettawa, IL USA
[6] Med Univ Vienna, Dept Med, Div Rheumatol, Vienna, Austria
[7] Hietzing Hosp, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2456
引用
收藏
页数:2
相关论文
共 1 条
  • [1] Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
    Smolen, Josef S.
    Emery, Paul
    Fleischmann, Roy
    van Vollenhoven, Ronald F.
    Pavelka, Karel
    Durez, Patrick
    Guerette, Benoit
    Kupper, Hartmut
    Redden, Laura
    Arora, Vipin
    Kavanaugh, Arthur
    [J]. LANCET, 2014, 383 (9914) : 321 - 332